We’ve Joined Glooko to Advance Diabetes Care. → Read more
News
Computerized IV Insulin Gives Better Control
June 21, 2016
An article published by Diabetes Times explores a seven-year study on the use of a computer-guided glucose management system (EndoTool) and its impact on various quality metrics, such as hyperglycemia, hypoglycemia and time to control.
Related posts
Blog
Temple Health to Present New Data on Patient-Specific Subcutaneous Insulin Dosing at DTM 2025
Temple Health to Present New Data on Patient-Specific Subcutaneous Insulin Dosing at DTM 2025
As the healthcare community gathers for the 2025 Diabetes Technology Society (DTS) meeting, a highly anticipated poster presentation from Temple University Health System and the Lewis Katz School of Medicine is set to highlight new evidence supporting patient-specific insulin dosing ...
Blog
Behind the Yellow Vests: My Experience Supporting Temple Health’s Success Reducing Hypoglycemia 2-3x
Behind the Yellow Vests: My Experience Supporting Temple Health’s Success Reducing Hypoglycemia 2-3x
As a Customer Success Manager of EndoTool, I've had the privilege of working with healthcare systems that are deeply committed to improving patient outcomes. Temple Health is one of those organizations. Their system-wide rollout of EndoTool SubQ wasn't just an ...
News
Monarch Medical Technologies Joins Glooko to Advance Connected Diabetes Care
Monarch Medical Technologies Joins Glooko to Advance Connected Diabetes Care
We are excited to announce that Monarch Medical Technologies, the creator of EndoTool® Glucose Management System, has been acquired by Glooko, a global leader in diabetes management solutions. For EndoTool customers, nothing changes in the care and support you receive. ...
Get in Touch
Ready to get started?
Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.
"*" indicates required fields